Estimation of Clinical Features and Outcomes of Effusive Constrictive Pericarditis in Patients Presented with Cardiac Tamponade

Estimation of Clinical Features and Outcomes of Effusive Constrictive Pericarditis in Patients Presented with Cardiac Tamponade - ELUCIDATE-ECP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045159

Enrollment

100

Registered

2021-08-15

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effusive constrictive pericarditis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergo (1) pericardiocentesis for pericardial effusion and (2) right heart catheterization to evaluate pre- and post-pericardiocentesis hemodynamics.

Exclusion criteria

Exclusion criteria: Patients who refused with participation in this study.

Design outcomes

Primary

Measure	Time frame
Incidence of effusive constrictive pericarditis	—

Secondary

Measure	Time frame
1)recurrence of pericardial effusion 2)surgical pericardial removal 3)1-year all-cause mortality, 1-year cardiovascular death, 1-year heart failure hospitalization, and cardiovascular event during one year 4)composite outcomes 1-year all-cause mortality and heart failure hospitalization 5)cardiac biomarker changes (BNP, NT-proBNP, and troponin) 6)renal function changes	—

Countries

Japan

Contacts

Public ContactWataru Fujimoto

Awaji medical center Cardiology

watarutaru_328@yahoo.co.jp+81799221200

Outcome results